Industrial Purity Standards For (3R,4S)-3-Hydroxy-4-Phenylazetidin-2-One
- Chiral Integrity: Maintains strict (3R,4S) stereochemistry crucial for downstream pharmaceutical efficacy.
- GMP Compliance: Production adheres to rigorous industrial purity benchmarks with comprehensive COA documentation.
- Bulk Scalability: Optimized manufacturing process ensures consistent supply for large-scale drug development.
In the realm of advanced pharmaceutical intermediates, the specification of chemical purity transcends simple percentage assays. For chiral building blocks like (3R,4S)-3-Hydroxy-4-phenyl-2-azetidinone, the distinction between laboratory-grade reagents and production-grade materials defines the success of subsequent synthetic steps. This compound, identified by CAS 132127-34-5, serves as a critical scaffold in the development of novel analgesics and anti-inflammatory agents. As a global manufacturer, understanding the nuances of impurity profiles and stereochemical stability is paramount for procurement officers and process chemists alike.
The demand for this intermediate has surged due to its utility in organic synthesis, particularly where the azetidin-2-one ring acts as a constrained geometry template. However, scaling from gram-scale research to kilogram-level production introduces variables that can compromise industrial purity. Factors such as residual solvents, enantiomeric excess, and heavy metal content must be controlled within tight parameters to ensure the final drug substance meets regulatory standards.
Defining Industrial vs. Laboratory-Grade Purity
When evaluating suppliers, it is essential to distinguish between materials intended for analytical reference and those designed for active pharmaceutical ingredient (API) synthesis. Laboratory-grade chemicals often prioritize immediate solubility or specific assay marks without regard for long-term stability or trace impurities. In contrast, industrial-grade production focuses on the robustness of the manufacturing process.
For (3R,4S)-3-Hydroxy-4-phenylazetidin-2-one, industrial purity implies a holistic approach to quality control. This includes monitoring the hydroxy group at the 3-position, which is susceptible to oxidation or elimination under improper storage conditions. A reputable supplier ensures that the synthesis route employed minimizes side reactions that could generate difficult-to-remove byproducts. When sourcing high-purity (3R,4S)-3-Hydroxy-4-phenylazetidin-2-one, buyers should verify that the production facility utilizes crystallization techniques that enhance chiral separation rather than relying solely on chromatographic purification, which is often cost-prohibitive at scale.
NINGBO INNO PHARMCHEM CO.,LTD. specializes in bridging this gap, offering materials that satisfy both the rigorous demands of process chemistry and the economic constraints of bulk procurement. The transition from pilot plant to commercial scale requires a partner who understands that purity is not just a number on a certificate, but a function of process control.
HPLC Assay and Impurity Profiles in GMP Production
High-Performance Liquid Chromatography (HPLC) remains the gold standard for quantifying the assay and impurity levels of azetidinone derivatives. In a GMP environment, the focus shifts from merely achieving a high main peak area to identifying and quantifying specific related substances. For this compound, critical impurities often include the (3S,4R) enantiomer, open-ring hydrolysis products, and unreacted starting materials from the cyclization step.
A comprehensive technical specification sheet should detail the limits for these impurities. Typically, industrial standards require the main assay to exceed 98.0%, with individual unknown impurities kept below 0.10% and total impurities below 1.0%. Chiral HPLC is particularly vital here to confirm the diastereomeric ratio, as the biological activity of the downstream pharmaceutical is heavily dependent on the (3R,4S) configuration.
Furthermore, residual solvent analysis is critical. Given that the compound is a white to off-white solid, solvents used during the final crystallization must be removed to levels compliant with ICH Q3C guidelines. Process chemists must also consider the stability of the beta-lactam ring during analysis; mobile phase pH must be controlled to prevent hydrolysis during the testing window, which could artificially inflate impurity readings.
Role of COA in Validating Batch Consistency
The Certificate of Analysis (COA) is the primary document validating the quality of any chemical shipment. For bulk buyers, the COA serves as a legal and technical guarantee that the material matches the agreed-upon specifications. A robust COA for this intermediate should include data on appearance, identification (IR/NMR), assay, melting point, and specific rotation.
Consistency across batches is the hallmark of a reliable supply chain. Variations in physical properties, such as particle size or polymorphic form, can affect dissolution rates in downstream reactions. Therefore, reviewing historical COA data is a best practice when negotiating bulk price agreements. Additionally, supporting documents such as the Safety Data Sheets (SDS) and Certificates of Origin (COO) are essential for customs clearance and regulatory compliance in different jurisdictions.
Procurement teams should demand transparency regarding the testing methods used to generate the COA. Whether the assay was determined by HPLC, GC, or titration can influence the perceived purity. NINGBO INNO PHARMCHEM CO.,LTD. ensures that all documentation is traceable to specific batch numbers, allowing for full accountability from synthesis to delivery.
Technical Specifications and Storage Requirements
To assist process engineers in planning their inventory and handling protocols, the following table outlines the standard physical and chemical properties expected for high-quality production batches of this intermediate.
| Parameter | Specification |
|---|---|
| Catalog Number | PA 04 97680 (Reference) |
| CAS Number | 132127-34-5 |
| Chemical Name | (3R,4S)-3-Hydroxy-4-phenyl-2-azetidinone |
| Molecular Formula | C9H9NO2 |
| Molecular Weight | 163.18 g/mol |
| Appearance | White to Off-White Solid |
| Purity (HPLC) | > 98.0% |
| Storage Conditions | 2-8°C Refrigerator |
| Shipping Conditions | Ambient (with proper insulation) |
Proper storage is critical for maintaining the integrity of the hydroxy-azetidinone structure. As indicated in the specifications, storage at 2-8°C is recommended to prevent thermal degradation. While shipping conditions may be ambient, prolonged exposure to high temperatures should be avoided upon receipt. The material should be kept in tightly closed containers to protect against moisture, which could facilitate ring-opening hydrolysis.
Conclusion
Securing a reliable supply of (3R,4S)-3-Hydroxy-4-phenylazetidin-2-one requires a partner who prioritizes technical excellence alongside commercial viability. The complexity of the synthesis and the sensitivity of the chiral centers demand a manufacturing process rooted in scientific rigor. By focusing on industrial purity standards, comprehensive COA validation, and consistent batch quality, pharmaceutical companies can mitigate risks in their drug development pipelines.
For organizations seeking a dependable source for this critical intermediate, NINGBO INNO PHARMCHEM CO.,LTD. offers the technical expertise and production capacity required to support global pharmaceutical development. Whether for biochemical research or large-scale API production, adherence to these purity standards ensures the efficacy and safety of the final therapeutic agents.